Literature DB >> 2540708

The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.

M G Rossmann1.   

Abstract

The tertiary structure of most icosahedral viral capsid proteins consists of an eight-stranded antiparallel beta-barrel with a hydrophobic interior. In a group of picornaviruses, this hydrophobic pocket can be filled by suitable organic molecules, which stop viral uncoating after attachment and penetration into the host cell. The antiviral activity of these agents is probably due to increased rigidity of the capsid protein, thereby inhibiting disassembly. The hydrophobic pocket may be an essential functional component of the protein and may have been conserved in the evolution of many viruses from a common precursor. Since eight-stranded anti-parallel beta-barrels, with a topology as in viral capsid proteins, are not generally found in other proteins involved in cell metabolism, antiviral agents that bind in the interior of viral capsid proteins are likely to be more virus-specific and less cytotoxic. Furthermore, the greatest conservation of viral capsid proteins occurs within this pocket, whereas the least conserved part is the antigenic exterior. Thus, compounds that bind to such a pocket are likely to be effective against a broader group of serologically distinct viruses. Discovery of antiviral agents of this type depends on designing compounds that can enter and fit snugly into the hydrophobic pocket of a particular viral capsid protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540708     DOI: 10.1016/0166-3542(89)90016-8

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  14 in total

Review 1.  Picornavirus morphogenesis.

Authors:  Ping Jiang; Ying Liu; Hsin-Chieh Ma; Aniko V Paul; Eckard Wimmer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

2.  Protein-Protein Interfaces in Viral Capsids Are Structurally Unique.

Authors:  Shanshan Cheng; Charles L Brooks
Journal:  J Mol Biol       Date:  2015-09-12       Impact factor: 5.469

3.  Tripeptide interference with human immunodeficiency virus type 1 morphogenesis.

Authors:  Stefan Höglund; Jin Su; Sara Sandin Reneby; Akos Végvári; Stellan Hjertén; Ida-Maria Sintorn; Hillary Foster; Yi-Pyng Wu; Ingela Nyström; Anders Vahlne
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.

Authors:  Susanne C Feil; Stephanie Hamilton; Guy Y Krippner; Bo Lin; Angela Luttick; Darryl B McConnell; Roland Nearn; Michael W Parker; Jane Ryan; Pauline C Stanislawski; Simon P Tucker; Keith G Watson; Craig J Morton
Journal:  ACS Med Chem Lett       Date:  2012-02-13       Impact factor: 4.345

5.  Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

Authors:  E De Clercq; N Yamamoto; R Pauwels; M Baba; D Schols; H Nakashima; J Balzarini; Z Debyser; B A Murrer; D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles.

Authors:  M J Almela; M E González; L Carrasco
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.

Authors:  E De Clercq; N Yamamoto; R Pauwels; J Balzarini; M Witvrouw; K De Vreese; Z Debyser; B Rosenwirth; P Peichl; R Datema
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.

Authors:  F G Hayden; K Andries; P A Janssen
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

9.  Complete coding sequence characterization and comparative analysis of the putative novel human rhinovirus (HRV) species C and B.

Authors:  Piyada Linsuwanon; Sunchai Payungporn; Kamol Suwannakarn; Thaweesak Chieochansin; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Virol J       Date:  2011-01-07       Impact factor: 4.099

Review 10.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.